Stereotactic ablative body radiotherapy (SABR) for locally advanced exocrine pancreatic cancer

Topic Status Complete

Stereotactic ablative body radiotherapy (SABR) for locally advanced exocrine pancreatic cancer.

Summary

 

Health Technology Wales researchers searched for evidence on stereotactic ablative body radiotherapy (SABR) for locally advanced exocrine pancreatic cancer. HTW’s Assessment Group decided not to progress this topic further due to the development of commissioning arrangements by Welsh Health Specialised Services Committee.

Topic Exploration Report

TER426 11.2022